<乌鸦传媒>Smart Inhaler for Asthma Misses the Mark for Boosting Adherence But patients on intervention had better asthma control at study end Sep 12, 2023
<乌鸦传媒>Climate Change a 'Major Threat' for Respiratory Patients, Experts Warn ERS statement suggests action for individual physicians with affected patients Sep 06, 2023
<乌鸦传媒>Neighborhood Factors in Childhood May Influence Asthma Risk High-opportunity locations tied to lower asthma incidence vs those with low opportunity Aug 29, 2023
<乌鸦传媒>Pediatric Allergic March Supported by Nationwide EHR Data Constellation of comorbid allergic conditions common among children Jul 26, 2023
<乌鸦传媒>Schools Aren't Prepared to Treat Asthma Attacks Every school should have a stock albuterol program Jun 06, 2023
<乌鸦传媒>Biologic Reduced Cough, Phlegm in Severe, Uncontrolled Asthma Separate trial analysis of tezepelumab showed no significant differences by sex May 24, 2023
<乌鸦传媒>Asthma, Eczema Tied to Osteoarthritis Risk Suggests OA is not just about wear and tear Mar 29, 2023
<乌鸦传媒>Digital Inhalers May Improve Uncontrolled Asthma Management Digital tools led to increased adherence and less medication escalation, trial reports Mar 23, 2023
<乌鸦传媒>Routine Bronchoscopy May Help Guide Therapies for Severe Asthma Procedure helped identify tissue-blood eosinophil mismatch, treatable comorbidities Mar 15, 2023
<乌鸦传媒>Study Reassures on Asthma Med Use in Pregnancy and Kids' Neuropsych Risks Use of leukotriene-receptor antagonists not tied to risks of ADHD, autism, Tourette syndrome Mar 07, 2023
<乌鸦传媒>Sustained Benefits With Mepolizumab in Severe Eosinophilic Asthma A fifth of patients no longer needed oral steroids 2 years after starting biologic Mar 01, 2023
<乌鸦传媒>Biologics for Asthma: Who Gets Them and Who Uses Them? Single-center study finds sluggish prescriptions, but patient-level barriers are also at work Feb 28, 2023
<乌鸦传媒>FDA Approves Novel Dual Rescue Inhaler for Asthma in Adults First-in-class Airsupra combines inhaled corticosteroid and short-acting beta2 agonist Jan 11, 2023
<乌鸦传媒>Use of Acid-Suppressive Medications in Infants May Lead to Allergic Diseases However, no meaningful associations were seen with prenatal exposure Jan 10, 2023
<乌鸦传媒>Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicity Also in TTHealthWatch: sodium levels and health outcomes Jan 07, 2023 podcast
<乌鸦传媒>COVID's Lasting Consequences for Kids Allergist Zachary Rubin, MD, details the post-COVID symptoms presenting at his clinic Dec 27, 2022 video
<乌鸦传媒>Kids Exposed to Smoke In Utero Had Better Lung Function If Moms Popped Vitamin C Follow-up findings from VCSIP trial shows better airway flow, decreased wheeze at age 5 years Nov 21, 2022
<乌鸦传媒>Asthma Deterioration Slowed With Combination Inhaler Albuterol-budesonide also reduced time with severe exacerbations Nov 14, 2022
<乌鸦传媒>Biologic Dupilumab Shows Sustained Benefit in Asthma Patients Reduced oral corticosteroid use, improved lung function maintained after nearly 2 years Oct 19, 2022
<乌鸦传媒>Mucus Too Sticky? NAC Injections May Help Trial shows benefit with IV N-acetylcysteine in hospital setting Sep 05, 2022
<乌鸦传媒>A Legacy of the Deepwater Horizon Spill: Asthma in Cleanup Workers Risk related to airborne chemicals from burning oil, natural gas Aug 19, 2022
<乌鸦传媒>Vulnerable Teens May Ask, Who'll Stop the Rain? Precipitation seen as trigger for airway inflammation May 19, 2022
<乌鸦传媒>Here's What Happened to Asthma, COPD Admissions After a Big Polluter Shut Down Correlation bolsters evidence that environmental air quality can be modified to good effect May 18, 2022
<乌鸦传媒>Two Drugs Better Than One for 'Rescue' Asthma Therapy Fixed-dose combo inhaler beats good old albuterol May 15, 2022
<乌鸦传媒>Nasal Spray Flu Vaccine No Problem for Kids With Asthma Contrary to CDC guidance, nasal spray did not increase asthma exacerbations Mar 28, 2022
<乌鸦传媒>First Generic OK'd for Popular Asthma, COPD Inhaler FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
<乌鸦传媒>Mepolizumab Reduces Need for Oral Steroids in Severe Asthma Some adults on the IL-5 antibody were able to stop taking systemic steroids Mar 02, 2022
<乌鸦传媒>Docs Debate Home Spirometry Is it ready for prime time or is it just a toy with possible serious consequences? Mar 02, 2022
<乌鸦传媒>Does One Mab Come Out on Top for Boosting Lung Function in Asthma? Dupilumab edges out other biologics, but differences were small in indirection comparison Mar 01, 2022
<乌鸦传媒>Mepolizumab Cuts Asthma Flare-Ups in Disadvantaged Kids Black and Hispanic children living in urban settings benefited from biologic therapy Mar 01, 2022
<乌鸦传媒>Many Severe Asthma Patients Achieve Remission on Biologics Year-long freedom from exacerbations without steroids reported in real-world study Feb 28, 2022
<乌鸦传媒>Tezepelumab Benefits Asthma Patients Year-Round Biologic consistently reduced the annualized asthma exacerbation rate Feb 28, 2022
<乌鸦传媒>Medical Approach May Work in Nasal Polyps With Asthma Omalizumab improves polyp symptom scores with low recurrence rate Feb 28, 2022
<乌鸦传媒>Glimpses of Hope for Lebrikizumab in Asthma Subgroup targeting may hold promise for biologic Feb 28, 2022
<乌鸦传媒>Dupilumab Continues to Show Promise in Eosinophilic Esophagitis Almost 60% of patients in LIBERTY EoE TREET study achieved remission Feb 27, 2022
<乌鸦传媒>Black, Latinx Adults With Asthma Benefit From Inhaled Glucocorticoid Add-On "Shovel-ready" intervention can help reduce disparities in asthma burden, researchers say Feb 26, 2022
<乌鸦传媒>Can Switching Inhalers Reduce Your Carbon Footprint? DPIs and pMDIs both effective for asthma control, but only one may help the earth Feb 08, 2022
<乌鸦传媒>FDA OKs First-in-Class Biologic for Severe Asthma Tezspire is first biologic for this condition with no phenotype or biomarker limitations Dec 20, 2021
<乌鸦传媒>Mixed Results With Anti-Interleukin Biologics in Asthma One shows promise; another fails miserably (and mysteriously) Oct 27, 2021
